Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

DNA Microarrays

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Drivers and Outcomes of Engagement in Non-Formal Special Interest Groups Among Japanese Emergency Physicians: An Activity Theory Analysis.

AEM education and training·2026

Same author

Microarray-Based Identification of Time-Sensitive miRNAs as Serum Quality Indicators in Liquid Biopsy.

Genes to cells : devoted to molecular & cellular mechanisms·2026

Same author

Testing and evaluating updated variants of the rurality index for Japan: a nationwide methodological study.

BMJ open·2026

Same author

Observed hand-movement reversals postdictively bias ambiguous motion judgements.

Scientific reports·2026

Same author

Predicting Clinical Response to Granulocyte/Monocyte Adsorption Apheresis in Treatment-Resistant Ulcerative Colitis.

Gastro hep advances·2026

Same author

Reduced Test Anxiety Among Medical Students in an Extremely Low-Stakes Examination.

Medical science educator·2026

Same journal

Corrigendum.

Anticancer research·2026

Same journal

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026

Same journal

Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

Anticancer research·2026

Same journal

Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

Anticancer research·2026

Same journal

Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

Anticancer research·2026

Same journal

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 4, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.

Yoshikatsu Koga¹, Nobuyoshi Yamazaki, Satoko Takizawa

¹Division of Developmental Therapeutics, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan. yhmatsum@east.ncc.go.jp.

Anticancer Research

|January 10, 2014

Summary

This summary is machine-generated.

A novel DNA microarray test shows higher sensitivity than the fecal occult blood test (FOBT) for detecting early-stage colorectal cancer (CRC), especially small, right-sided tumors. This gene profiling assay offers improved colorectal cancer screening for specific patient groups.

Keywords:

Cancer screening DNA microarray colorectal cancer fecal RNA fecal occult blood test gene profiling

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Related Experiment Videos

Last Updated: May 4, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Area of Science:

Oncology
Molecular Diagnostics
Gastroenterology

Background:

Fecal occult blood test (FOBT) has limitations in detecting small, right-sided, non-metastatic colorectal cancer (CRC), with half of patients showing negative results.
Early detection of CRC is crucial for improving patient outcomes and survival rates.

Purpose of the Study:

To evaluate the effectiveness of a highly sensitive DNA microarray assay for colorectal cancer (CRC) screening.
To compare the diagnostic performance of the DNA microarray assay against FOBT using fecal samples.

Main Methods:

Gene profiling was performed on fecal samples from 53 CRC patients and 61 healthy controls using a highly sensitive DNA chip.
Participants were divided into training and validation sets for assay evaluation.

Main Results:

The DNA microarray assay identified 43 differentially expressed genes in CRC patients compared to healthy controls (p<0.05).
In both training and validation sets, the DNA chip assay demonstrated high sensitivity (85.4% and 85.2%) and specificity (85.2% and 85.7%).
The DNA chip assay showed significantly higher sensitivity than FOBT for detecting small, right-sided, early-stage CRC, particularly surface tumors (p=0.023 and p=0.019).

Conclusions:

A gene profiling assay using a highly sensitive DNA chip is more effective than FOBT for detecting specific types of colorectal cancer.
This DNA microarray approach offers a promising advancement in colorectal cancer screening, especially for early-stage and right-sided tumors.